{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:00:57Z","timestamp":1771473657841,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1008037","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000}}],"reference-count":82,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1008037","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T17:45:51Z","timestamp":1596476751000},"page":"e1008037","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Optimising efficacy of antibiotics against systemic infection by varying dosage quantities and times"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9117-7041","authenticated-orcid":true,"given":"Andy","family":"Hoyle","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0246-3821","authenticated-orcid":true,"given":"David","family":"Cairns","sequence":"additional","affiliation":[]},{"given":"Iona","family":"Paterson","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2368-7864","authenticated-orcid":true,"given":"Stuart","family":"McMillan","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7649-5669","authenticated-orcid":true,"given":"Gabriela","family":"Ochoa","sequence":"additional","affiliation":[]},{"given":"Andrew P.","family":"Desbois","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"pcbi.1008037.ref001","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","article-title":"Antibacterial resistance worldwide: causes, challenges and responses","volume":"10","author":"SB Levy","year":"2004","journal-title":"Nat Med."},{"key":"pcbi.1008037.ref002","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"R Davidson","year":"2002","journal-title":"N Engl J Med"},{"key":"pcbi.1008037.ref003","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/344657","article-title":"Chaisson, RE. Tuberculosis Drug Resistance: A Global Threat","volume":"36","author":"JB Nachega","year":"2003","journal-title":"Clin Infect Dis"},{"key":"pcbi.1008037.ref004","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea? Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone","volume":"55","author":"M Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"pcbi.1008037.ref005","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/AAC.02093-13","article-title":"First three neisseria gonorrhoeae isolates with high-Level resistance to azithromycin in sweden: A threat to currently available dual-Antimicrobial regimens for treatment of gonorrhea?","volume":"58","author":"M Unemo","year":"2014","journal-title":"Antimicrob. Agents Chemother"},{"key":"pcbi.1008037.ref006","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/AAC.41.11.2321","article-title":"Why Are Antibiotic Resistance Genes So Resistant to Elimination?","volume":"41","author":"AA Salyers","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"pcbi.1008037.ref007","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1054\/drup.2000.0167","article-title":"The impact of antibiotic use on resistance development and persistence","volume":"3","author":"TM Barbosa","year":"2000","journal-title":"Drug Resist. Updat"},{"key":"pcbi.1008037.ref008","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrmicro2319","article-title":"Antibiotic resistance and its cost: is it possible to reverse resistance?","volume":"8","author":"DI Andersson","year":"2010","journal-title":"Nat.Rev Microbiol"},{"key":"pcbi.1008037.ref009","article-title":"UK Five Year Antimicrobial Resistance Strategy 2013 to 2018","volume":"43","author":"Department of Health & Department for Environment Food and Rural Affairs (DEFRA)","year":"2013","journal-title":"Dep. Heal. Dep. Environ. Food Rural Aff"},{"key":"pcbi.1008037.ref010","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1462-2920.2006.01054.x","article-title":"Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment","volume":"8","author":"C Cabello F","year":"2006","journal-title":"Environ Microbiol"},{"key":"pcbi.1008037.ref011","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.scitotenv.2019.06.134","article-title":"Identifying hotspots for antibiotic resistance emergence and selection, and elucidating pathways to human exposure: Application of a systems-thinking approach to aquaculture systems","volume":"687","author":"LA Brunton","year":"2019","journal-title":"Sci Total Environ"},{"key":"pcbi.1008037.ref012","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.phyto.011108.135838","article-title":"Models of fungicide resistance dynamics","volume":"46","author":"F van den Bosch","year":"2008","journal-title":"Annu Rev Phytopathol"},{"key":"pcbi.1008037.ref013","doi-asserted-by":"crossref","first-page":"20140083","DOI":"10.1098\/rstb.2014.0083","article-title":"Antimicrobial resistance in humans, livestock and the wider environment","volume":"370","author":"M Woolhouse","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"pcbi.1008037.ref014","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1073\/pnas.1503141112","article-title":"Global trends in antimicrobial use in food animals","volume":"112","author":"TP Van Boeckel","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"pcbi.1008037.ref015","first-page":"274","article-title":"Restricting Antimicrobial Use in Food Animals: Lessons from Europe","volume":"6","author":"C Cogliani","year":"2011","journal-title":"Microbe"},{"key":"pcbi.1008037.ref016","first-page":"65","article-title":"The Microbial Threat: The Copenhagen Recommendation","volume":"10","year":"1998","journal-title":"Microb Ecol Health Dis"},{"key":"pcbi.1008037.ref017","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0163-7258(00)00077-2","article-title":"The dose-response relationship in Phase I clinical trials and beyonduse, meaning, and assessment","volume":"88","author":"G Emilien","year":"2000","journal-title":"Pharmacol Ther"},{"key":"pcbi.1008037.ref018","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12916-019-1348-z","article-title":"Optimising trial designs to identify appropriate antibiotic treatment durations","volume":"17","author":"KB Pouwels","year":"2019","journal-title":"BMC Med"},{"issue":"4","key":"pcbi.1008037.ref019","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0924-8579(00)00142-4","article-title":"Antibiotic treatment for animals: Effect on bacterial population and dosage regimen optimisation","volume":"14","author":"FS Aliabadi","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"pcbi.1008037.ref020","doi-asserted-by":"crossref","first-page":"20180255","DOI":"10.1098\/rstb.2018.0255","article-title":"One model to rule them all? Modelling approaches across OneHealth for human, animal and plant epidemics","volume":"374","author":"A Kleczkowski","year":"2019","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"12","key":"pcbi.1008037.ref021","doi-asserted-by":"crossref","first-page":"e4036","DOI":"10.1371\/journal.pone.0004036","article-title":"The impact of different antibiotic regimens on the emergence of antimicrobial-resistant bacteria","volume":"3","author":"EMC D\u2019Agata","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"pcbi.1008037.ref022","doi-asserted-by":"crossref","first-page":"e29838","DOI":"10.1371\/journal.pone.0029838","article-title":"One-Size-Fits-All? Optimizing Treatment Duration for Bacterial Infections","volume":"7","author":"P Geli","year":"2012","journal-title":"PLoS One"},{"issue":"23","key":"pcbi.1008037.ref023","doi-asserted-by":"crossref","first-page":"8331","DOI":"10.1073\/pnas.1400352111","article-title":"Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections","volume":"111","author":"P Ankomah","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"pcbi.1008037.ref024","doi-asserted-by":"crossref","first-page":"e1004857","DOI":"10.1371\/journal.pcbi.1004857","article-title":"Integrating antimicrobial therapy with host immunity to fight drug-resistant infections: classical vs. adaptive treatment","volume":"12","author":"E Gjini","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"pcbi.1008037.ref025","volume-title":"Adaptation in natural and artificial systems: an introductory analysis with applications to biology, control, and artificial intelligence","author":"J Holland","year":"1975"},{"issue":"4","key":"pcbi.1008037.ref026","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10710-007-9041-y","article-title":"An evolutionary approach to cancer chemotherapy scheduling","volume":"8","author":"G Ochoa","year":"2007","journal-title":"Genet Program Evolvable Mach"},{"issue":"6","key":"pcbi.1008037.ref027","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00500-013-1043-5","article-title":"Population-based optimization of cytostatic\/cytotoxic combination cancer chemotherapy","volume":"17","author":"G Ochoa","year":"2013","journal-title":"Soft Comput"},{"key":"pcbi.1008037.ref028","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-44874-8","volume-title":"Introduction to Evolutionary Computing","author":"AE Eiben","year":"2015"},{"key":"pcbi.1008037.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep37853","article-title":"Optimising antibiotic usage to treat bacterial infections","volume":"6","author":"IK Paterson","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"pcbi.1008037.ref030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1142\/S0218339018500031","article-title":"Optimal Dosing Strategies Against Susceptible and Resistant Bacteria","volume":"26","author":"A Khan","year":"2018","journal-title":"J Biol Syst"},{"issue":"6","key":"pcbi.1008037.ref031","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12195-017-0507-6","article-title":"Applying Optimization Algorithms to Tuberculosis Antibiotic Treatment Regimens","volume":"10","author":"JM Cicchese","year":"2017","journal-title":"Cell Mol Bioeng"},{"key":"pcbi.1008037.ref032","doi-asserted-by":"crossref","first-page":"e1002104","DOI":"10.1371\/journal.pbio.1002104","article-title":"Using a Sequential Regimen to Eliminate Bacteria at Sub-lethal Antibiotic Dosages","volume":"13","author":"A Fuentes-Hernandez","year":"2015","journal-title":"PLoS Biol"},{"issue":"3","key":"pcbi.1008037.ref033","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41559-016-0050","article-title":"The unconstrained evolution of fast and efficient antibiotic-resistant bacterial genomes","volume":"1","author":"C Reding-Roman","year":"2017","journal-title":"Nat Ecol Evol"},{"issue":"2","key":"pcbi.1008037.ref034","doi-asserted-by":"crossref","first-page":"e1006012","DOI":"10.1371\/journal.pcbi.1006012","article-title":"Mathematical modelling of the antibiotic-induced morphological transition of Pseudomonas aeruginosa","volume":"14","author":"C Spalding","year":"2018","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"pcbi.1008037.ref035","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s11538-011-9698-5","article-title":"Selecting Against Antibiotic-Resistant Pathogens: Optimal Treatments in the Presence of Commensal Bacteria","volume":"74","author":"R Pe\u00f1a-Miller","year":"2012","journal-title":"Bull Math Biol"},{"issue":"8","key":"pcbi.1008037.ref036","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/jac\/dkr198","article-title":"Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agents","volume":"66","author":"AP Desbois","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"pcbi.1008037.ref037","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/B978-0-12-394805-2.00002-6","article-title":"Utility of greater wax moth larva (Galleria mellonella) for evaluating the toxicity and efficacy of new antimicrobial agents","volume":"78","author":"AP Desbois","year":"2012","journal-title":"Adv Appl Microbiol"},{"issue":"1","key":"pcbi.1008037.ref038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-015-0466-9","article-title":"Larva of the greater wax moth, Galleria mellonella, is a suitable alternative host for studying virulence of fish pathogenic Vibrio anguillarum","volume":"15","author":"S McMillan","year":"2015","journal-title":"BMC Microbiol"},{"issue":"34","key":"pcbi.1008037.ref039","doi-asserted-by":"crossref","first-page":"962","DOI":"10.15585\/mmwr.mm6734a5","article-title":"Notes from the Field: Fatal Vibrio anguillarum Infection in an Immunocompromised Patient\u2014Maine, 2017","volume":"67","author":"JA Sinatra","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"pcbi.1008037.ref040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0723-2020(11)80400-5","article-title":"Identification and typing of Vibrio anguillarum\u2014A comparison of different methods","volume":"18","author":"B Austin","year":"1995","journal-title":"Syst Appl Microbiol"},{"key":"pcbi.1008037.ref041","author":"RA Miller","year":"2014","edition":"2"},{"issue":"25","key":"pcbi.1008037.ref042","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/j100540a008","article-title":"Exact stochastic simulation of coupled chemical reactions","volume":"81","author":"DT Gillespie","year":"1977","journal-title":"J Phys Chem"},{"issue":"4","key":"pcbi.1008037.ref043","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1063\/1.1378322","article-title":"Approximate accelerated stochastic simulation of chemically reacting systems","volume":"115","author":"DT Gillespie","year":"2001","journal-title":"J Chem Phys"},{"issue":"7","key":"pcbi.1008037.ref044","doi-asserted-by":"crossref","first-page":"e1007211","DOI":"10.1371\/journal.pcbi.1007211","article-title":"Mathematical model predicts anti-adhesion\u2013antibiotic\u2013debridement combination therapies can clear an antibiotic resistant infection","volume":"15","author":"PA Roberts","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"pcbi.1008037.ref045","volume-title":"Natural Computing Series (Springer","author":"A Eiben","year":"2015"},{"key":"pcbi.1008037.ref046","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"KN Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"pcbi.1008037.ref047","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/07420528509055888","article-title":"Annual Changes in the Greater Wax Moth (Galleria Mellonella L.) Development and Sensitivity to Juvenilizing Treatments","volume":"2","author":"MI Bogu","year":"1985","journal-title":"Chronobiol Int"},{"issue":"3","key":"pcbi.1008037.ref048","first-page":"444","article-title":"Study of the life cycle of greater wax moth (Galleria mellonella) under storage conditions in relation to different weather conditions","volume":"6","author":"G Kumar","year":"2018","journal-title":"J Entomol Zool Stud"},{"issue":"8","key":"pcbi.1008037.ref049","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1109\/4235.996017","article-title":"A fast and elitist multi-objective genetic algorithm: NSGA-II","volume":"6","author":"K Deb","year":"2002","journal-title":"IEEE Trans Evol Comput"},{"issue":"6","key":"pcbi.1008037.ref050","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000088960","article-title":"Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin","volume":"51","author":"S Al Dahouk","year":"2005","journal-title":"Chemotherapy"},{"issue":"5","key":"pcbi.1008037.ref051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nmicrobiol.2016.20","article-title":"Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence","volume":"1","author":"B Van den Bergh","year":"2016","journal-title":"Nat Microbiol"},{"issue":"4","key":"pcbi.1008037.ref052","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1023\/A:1008202821328","article-title":"Differential evolution\u2014a simple and efficient heuristic for global optimization over continuous spaces","volume":"11","author":"R Storn","year":"1997","journal-title":"J Glob Optim"},{"key":"pcbi.1008037.ref053","volume-title":"Differential Evolution: A Practical Approach to Global Optimization","author":"K Price","year":"2005"},{"issue":"2","key":"pcbi.1008037.ref054","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1162\/106365601750190398","article-title":"Completely derandomized self-adaptation in evolution strategies","volume":"9","author":"N Hansen","year":"2001","journal-title":"Evol Comput"},{"issue":"1","key":"pcbi.1008037.ref055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1162\/evco.2007.15.1.1","article-title":"Covariance Matrix Adaptation for Multi-objective Optimization","volume":"15","author":"C Igel","year":"2007","journal-title":"Evol Comput"},{"issue":"2","key":"pcbi.1008037.ref056","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/AAC.41.2.363","article-title":"The population dynamics of antimicrobial chemotherapy","volume":"41","author":"M Lipsitch","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"pcbi.1008037.ref057","doi-asserted-by":"crossref","first-page":"e2001110","DOI":"10.1371\/journal.pbio.2001110","article-title":"How to use a chemotherapeutic agent when resistance to it threatens the patient","volume":"15","author":"E Hansen","year":"2017","journal-title":"PLoS biology"},{"issue":"4","key":"pcbi.1008037.ref058","doi-asserted-by":"crossref","first-page":"e01800","DOI":"10.1128\/AAC.01800-18","article-title":"Impact of an antimicrobial stewardship intervention on within-and between-patient daptomycin resistance evolution in vancomycin-resistant Enterococcus faecium","volume":"63","author":"CL Kinnear","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"pcbi.1008037.ref059","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/AAC.00447-06","article-title":"Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacinazithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever","volume":"51","author":"CM Parry","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"pcbi.1008037.ref060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1445-5994.2004.00601.x","article-title":"Short course intravenous benzylpenicillin treatment of adults with meningococcal disease","volume":"34","author":"S Briggs","year":"2004","journal-title":"Intern Med J"},{"issue":"2","key":"pcbi.1008037.ref061","first-page":"25","article-title":"Antibiotic dosing in critical illness","volume":"66","author":"C McKenzie","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"pcbi.1008037.ref062","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","article-title":"Breaking the cycle: strategies for 163 cases of recurrent Clostridium difficile","volume":"97","author":"LV McFarland","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"pcbi.1008037.ref063","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1099\/jmm.0.45753-0","article-title":"Alternative treatments for Clostridium difficile disease: What really works?","volume":"54","author":"LV McFarland","year":"2005","journal-title":"J. Med. Microbiol"},{"issue":"3","key":"pcbi.1008037.ref064","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3934\/mbe.2014.11.547","article-title":"A Model of optimal dosing of antibiotic treatment in biofilm","volume":"11","author":"M Imran","year":"2014","journal-title":"Math Biosci Eng"},{"issue":"6","key":"pcbi.1008037.ref065","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/jac\/dky075","article-title":"Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study","volume":"73","author":"T Gouliouris","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"7443","key":"pcbi.1008037.ref066","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/bmj.38049.490255.DE","article-title":"Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial","volume":"328","author":"G Agarwal","year":"2004","journal-title":"BMJ"},{"issue":"7554","key":"pcbi.1008037.ref067","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/bmj.332.7554.1355","article-title":"Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study","volume":"332","author":"R el Moussaoui","year":"2006","journal-title":"BMJ"},{"issue":"9","key":"pcbi.1008037.ref068","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamainternmed.2016.3633","article-title":"Duration of Antibiotic Treatment in Community Acquired Pneumonia: A Multicenter Randomized Clinical","volume":"176","author":"A Uranga","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"8","key":"pcbi.1008037.ref069","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/adc.2008.151563","article-title":"Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children","volume":"94","author":"DE Karageorgopoulos","year":"2009","journal-title":"Arch Dis Child"},{"issue":"6","key":"pcbi.1008037.ref070","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/clinids\/5.6.1033","article-title":"Antimicrobial resistance in hospital organisms and its relation to antibiotic use","volume":"5","author":"JE McGowan","year":"1983","journal-title":"Rev Infect Dis"},{"issue":"1","key":"pcbi.1008037.ref071","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/tropej\/50.1.26","article-title":"Antibiotic resistance patterns in nosocomial gram-negative bacterial infections in units with heavy antibiotic usage","volume":"50","author":"H Ariffin","year":"2004","journal-title":"J Trop Pediatr"},{"issue":"3","key":"pcbi.1008037.ref072","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/clinids\/11.3.361","article-title":"Inoculum effect","volume":"11","author":"I Brook","year":"1989","journal-title":"Rev infect Dis"},{"issue":"1","key":"pcbi.1008037.ref073","article-title":"The inoculum effect and band\u2010pass bacterial response to periodic antibiotic treatment","volume":"8","author":"C Tan","year":"2012","journal-title":"Mol Syst Biol"},{"issue":"10","key":"pcbi.1008037.ref074","doi-asserted-by":"crossref","first-page":"e1005098","DOI":"10.1371\/journal.pcbi.1005098","article-title":"Population density modulates drug inhibition and gives rise to potential bistability of treatment outcomes for bacterial infections","volume":"12","author":"J Karslake","year":"2016","journal-title":"PLOS Comput Biol"},{"issue":"4","key":"pcbi.1008037.ref075","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dkn554","article-title":"Functional relationship between bacterial cell density and the efficacy of antibiotics","volume":"63","author":"KI Udekwu","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"22","key":"pcbi.1008037.ref076","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1073\/pnas.94.22.12106","article-title":"Evaluating treatment protocols to prevent antibiotic resistance","volume":"94","author":"S Bonhoeffer","year":"1997","journal-title":"P Natl Acad Sci USA"},{"issue":"3","key":"pcbi.1008037.ref077","first-page":"297","article-title":"Pharmacovigilance study of azithromycin tablets (500 mg) in the treatment of adult patients with respiratory tract infections","volume":"13","author":"MP Alvarez","year":"2000","journal-title":"Rev Esp Quimioter"},{"issue":"60","key":"pcbi.1008037.ref078","first-page":"445","article-title":"Patient adherence in respiratory tract infections: ceftibuten versus other antibiotics (particular study)","volume":"10","author":"P Kardas","year":"2001","journal-title":"Pol Merkur Lekarski"},{"issue":"6","key":"pcbi.1008037.ref079","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/jac\/dkf046","article-title":"Patient compliance with antibiotic treatment for respiratory tract infections","volume":"49","author":"P Kardas","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"pcbi.1008037.ref080","first-page":"269","article-title":"Factors affecting therapeutic compliance: A review from the patient\u2019s perspective","volume":"4","author":"SC Li","year":"2008","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"pcbi.1008037.ref081","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jac\/dkh482","article-title":"Antibiotic cycling or rotation: a systematic review of the evidence of efficacy","volume":"55","author":"EM Brown","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"pcbi.1008037.ref082","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1745-6215-15-277","article-title":"Antibiotic rotation strategies to reduce antimicrobial resistance in gram-negative bacteria in European intensive care units: study protocol for a cluster-randomized crossover controlled trial","volume":"15","author":"PJ van Duijn","year":"2014","journal-title":"Trials"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1008037","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T17:50:22Z","timestamp":1599069022000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008037"}},"subtitle":[],"editor":[{"given":"Rustom","family":"Antia","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":82,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1008037","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1008037","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]}}}